Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Other Accumulated Expenses (2016 - 2025)

Chemours (CC) has 11 years of Other Accumulated Expenses data on record, last reported at $102.0 million in Q2 2025.

  • For Q2 2025, Other Accumulated Expenses fell 20.31% year-over-year to $102.0 million; the TTM value through Jun 2025 reached $102.0 million, down 20.31%, while the annual FY2024 figure was $115.0 million, 22.3% down from the prior year.
  • Other Accumulated Expenses reached $102.0 million in Q2 2025 per CC's latest filing, down from $117.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $239.0 million in Q2 2022 and bottomed at $73.0 million in Q3 2021.
  • Average Other Accumulated Expenses over 5 years is $119.4 million, with a median of $117.0 million recorded in 2025.
  • Peak YoY movement for Other Accumulated Expenses: soared 191.46% in 2022, then dropped 24.56% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $73.0 million in 2021, then increased by 1.37% to $74.0 million in 2022, then soared by 100.0% to $148.0 million in 2023, then decreased by 22.3% to $115.0 million in 2024, then decreased by 11.3% to $102.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $102.0 million in Q2 2025, $117.0 million in Q1 2025, and $115.0 million in Q4 2024.